Athyrium Capital Management’s Apollo Endosurgery, Inc. APEN Stock Holding History

Athyrium Capital Management’s Portfolio APEN Stock Details APEN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q4	–	Sell	-252,079	Closed	-$1.81M	–	4
2018 Q3	$1.81M	Hold	252,079	–	–	1.44%	3
2018 Q2	$1.76M	Hold	252,079	–	–	1.9%	3
2018 Q1	$1.58M	Hold	252,079	–	–	0.97%	4
2017 Q4	$1.41M	Buy	+252,079	New	+$1.15M	0.84%	5

Other funds holding APEN

SCM

Stonepine Capital Management Bend, Oregon $250M AUM 77.6% 1-Year Est. Return

NCM

Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return

CPMG Inc Dallas, Texas $37.1M AUM 74.35% 1-Year Est. Return

Gagnon Securities New York $433M AUM 29.08% 1-Year Est. Return

Luther King Capital Management (LKCM) Fort Worth, Texas $23.1B AUM 21.31% 1-Year Est. Return

Gagnon Advisors New York $136M AUM 21.55% 1-Year Est. Return

Russell Investments Group London, United Kingdom $93.1B AUM 28.26% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Athyrium Capital Management's APEN Position: Q4 2018 in Review

Athyrium Capital Management sold out of Apollo Endosurgery, Inc. (APEN) in Q4 2018, closing a stake of 252,079 shares — an estimated $1.81M sold.

Athyrium Capital Management first reported a position in APEN in Q4 2017 and held it in 4 quarters. The position peaked at $1.81M in Q3 2018. 35 funds tracked by Wall St. Rank hold APEN as of Q4 2018.

Athyrium Capital Management reported no remaining Apollo Endosurgery, Inc. position as of Q4 2018 after selling out during the quarter.
Athyrium Capital Management sold 252,079 Apollo Endosurgery, Inc. shares in Q4 2018, an estimated $1.81M.
Athyrium Capital Management first reported a position in Apollo Endosurgery, Inc. in Q4 2017 and held it in 4 quarters.
Athyrium Capital Management's Apollo Endosurgery, Inc. position peaked at $1.81M in Q3 2018.
35 funds tracked by Wall St. Rank held Apollo Endosurgery, Inc. as of Q4 2018.

Based on Athyrium Capital Management's 13F filing for Q4 2018, filed 12 Feb 2019.